logo

For the Inventor, By the Inventor

Uttar Pradesh, India

Anand Prakash Tiwari

This inventor holds 12 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Teva Pharmaceutical Industries Limited. Active years: 2008-2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Anand Prakash Tiwari. Retrieved from https://idiyas.com/inventor/anand-prakash-tiwari

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 12 

 

Average Co-Inventor Count = 3.7

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:

goldMedal12 out of 505 
 
Teva Pharmaceutical Industries Limited
 patents

Years Active: 2008-2012

Loading Chart...
Loading Chart...
12 patents (USPTO):Explore Patents
1. 8212071 - Asymmetric synthesis of (S)-(+)-3-(aminomethyl)-5-methylhexanoic acid (2012-07-03),
2. 8097754 - Synthesis of (S)-(+)-3-(aminomethyl)-5-methyl hexanoic acid (2012-01-17),
3. 7973196 - Asymmetric synthesis of (S)-(+)-3-(aminomethyl)-5-methylhexanoic acid (2011-07-05),
4. 7960583 - Asymmetric synthesis of (S)-(+)-3-(aminomethyl)-5-methylhexanoic acid (2011-06-14),
5. 7923575 - Asymmetric synthesis of (S)-(+)-3-(aminomethyl)-5-methylhexanoic acid (2011-04-12),
6. 7851651 - Asymmetric synthesis of (S)-(+)-3-(aminomethyl)-5-methylhexanoic acid (2010-12-14),
7. 7687656 - Asymmetric synthesis of (S)-(+)-3-(aminomethyl)-5-methylhexanoic acid (2010-03-30),
8. 7586005 - Asymmetric synthesis of (S)-(+)-3-(aminomethyl)-5-methylhexanoic acid (2009-09-08),
9. 7563923 - Chiral 3-carbamoylmethyl-5-methyl hexanoic acids, key intermediates for the synthesis of (S)-Pregabalin (2009-07-21),
10. 7470812 - Chiral 3-carbamoylmethyl-5-methyl hexanoic acids, key intermediates for the synthesis of (S)-Pregabalin (2008-12-30),
11. 7465826 - Chiral 3-carbamoylmethyl-5-methyl hexanoic acids, key intermediates for the synthesis of (S)-pregabalin (2008-12-16),
12. 7446220 - Asymmetric synthesis of (S)-(+)-3-(aminomethyl)-5-methylhexanoic acid (2008-11-04),

Title: Inventor Spotlight: Anand Prakash Tiwari

Introduction

Anand Prakash Tiwari, based in Uttar Pradesh, India, is a prominent inventor in the pharmaceutical field. With a remarkable portfolio of 12 patents, he has made significant contributions to the development of innovative synthesis processes that advance medicinal chemistry.

Latest Patents

Among his latest inventions, Tiwari has focused on the asymmetric synthesis of (S)-(+)-3-(aminomethyl)-5-methylhexanoic acid. This invention involves novel processes for synthesizing both (S)-(+)-3-(aminomethyl)-5-methylhexanoic acid and (S)-Pregabalin, along with their intermediates. His work includes providing syntheses of these compounds through a chiral intermediate, showcasing his expertise in creating essential pharmaceutical compounds.

Career Highlights

Currently, Anand Prakash Tiwari is employed at Teva Pharmaceutical Industries Limited, a global leader in generic and specialty pharmaceuticals. His innovative approach and in-depth knowledge have significantly contributed to various research projects and drug development initiatives within the company.

Collaborations

Throughout his career, Tiwari has collaborated with notable coworkers such as Vinod Kumar Kansal and Brijnath P Chaurasia. Together, they have worked on various projects that not only broaden the scope of their research but also strengthen their contributions to the pharmaceutical industry.

Conclusion

Anand Prakash Tiwari continues to be an influential figure in the realm of pharmaceutical innovations. His dedication to advancing synthesis processes and his collaborations with fellow innovators highlight the importance of teamwork in achieving breakthroughs in the industry. As his work progresses, Tiwari's inventions will undoubtedly play a crucial role in enhancing the efficacy of medications and treatments available today.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…